Business
ChromaDex Wins International 2022 European NutraIngredients Award for Developing the Science Behind Niagen®
The ChromaDex External Research Program (CERPTM) was honored in the “Nutrition Research Project” category for pioneering research behind Niagen® LOS
About this update from Niagen Bioscience, Inc.
[{"type":"text","content":"\nThe ChromaDex External Research Program (CERPTM) was honored in the “Nutrition Research Project” category for pioneering research behind Niagen®\n\n LOS ANGELES--(BUSINESS WIRE)--\nChromaDex Corp. (NASDAQ:CDXC) announced today that NutraIngredients, a leading news source for the nutrition industry, recently honored the ChromaDex External Research Program (CERPTM) with a 2022 European NutraIngredients Award in the “Nutrition Research Project” category for developing the science behind ChromaDex’s proprietary and patented Niagen® nicotinamide riboside (NR) ingredient. Niagen is an efficient precursor for the essential cellular coenzyme nicotinamide adenine dinucleotide (NAD+), which stimulates cellular energy production and supports cellular repair. Decreased NAD+ levels have been associated with age-related decline in overall health.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517005235/en/ChromaDex Wins 2022 NutraIngredients Award for Developing the Science Behind Niagen® (Graphic: Business Wire)\nHonoring the best and brightest in ingredients, products, companies, people, and initiatives in the nutrition and dietary supplement industry, the NutraIngredients Awards spotlight innovation, long-term market success, and cutting-edge research. The Nutrition Research Project category assessed companies that showcased sound science to back up claims and inform business decisions, and awarded the best game-changing nutrition research projects that push boundaries of nutritional science.\n\n“As a pioneer of NAD+ and NR science via Niagen, we are honored to receive this award and garner recognition for the innovative research CERP is leading throughout the world,” said Dr. Andrew Shao, ChromaDex Senior Vice President of Global Regulatory and Scientific Affairs. “Through CERP, we are furthering research on the benefits of Niagen and NAD+ by collaborating with the global research community and the NutraIngredients Award for the best Nutrition Research Project reinforces our dedication to this.”\n\nCERP is an essential component of ChromaDex’s Research and Development Program, where Niagen and other materials (bulk, clinical, and matching placebo) are provided, in kind, for outstanding research proposals. Additionally, a group of ChromaDex interdisciplinary scientists sup...